Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 5Head & Neck 4Gynecologic 4Breast 4Other solid neoplasm 3Other hematologic neoplasm 3Other 2Genitourinary 2Gastrointestinal 2Lymphoid 1Dermatologic 1

Conditions

Overweight 2Obesity 2Breast Neoplasms 2

Interventions

Exercise 15Metformin 14Surveys and Questionnaires 12Radiotherapy 9Methods 7naloxegol 6Nutrition Assessment 6Counseling 6alvimopan 5Resistance Training 5Psychiatric Rehabilitation 5Exenatide 5Early Intervention, Educational 5Diet Therapy 5Diet 5Sugars 4Mindfulness-Based Stress Reduction 4Injections 4Fibroblast Growth Factor 7 4Educational Status 4Drug Therapy 4Vitamin D 3Therapeutics 3Standard of Care 3Liraglutide 3Interviews as Topic 3Fentanyl 3Cryotherapy 3Cognitive Behavioral Therapy 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Bupropion × Other × Clear all
NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
53 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Overweight

NCT03581630 2018-08-29

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Gangnam Severance Hospital

Phase NA Completed
72 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡